Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients -a Randomized Controlled Trial With 6 Months Follow-up

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Anxiety and depression are associated with work disability, lower participation rate in cardiac rehabilitation and unfavourable life style changes following a coronary heart disease (CHD) event. The prevalence of clinically significant symptoms of depression and anxiety in CHD patients has been estimated to 30-50%. Furthermore, depression and anxiety are associated with a significant increased risk of subsequent major adverse cardiovascular events and mortality in CHD patients. Psychological interventions for anxiety and depression in CHD patients have demonstrated small and uncertain effects of symptoms, and no effect on cardiovascular outcomes. Therefore, testing the effectiveness of specific psychological interventions that may affect central mechanisms for cardiovascular outcomes, has been requested. The Attention training (ATT) Study is a randomized controlled trial comparing group-attention training to wait-list control in 64 patients who experience significant anxiety and depression after a CHD event. It will also be explored whether reduction in psychological symptoms is correlated with changes in biological markers with a potential link to cardiovascular outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Established coronary heart disease as main somatic disease

• \>=8 on either HADS-anxiety or depression subscale

• Age 18 - 65 years

• The ability to understand and speak Norwegian language,

• Willingness and ability to give informed consent.

Locations
Other Locations
Norway
Vestre Viken Trust Drammen hospital
RECRUITING
Drammen
Hospital of Vestfold
NOT_YET_RECRUITING
Tønsberg
Contact Information
Primary
John Munkhaugen, MD,PhD
johmun@vestreviken.no
+4797524194
Backup
Toril Dammen, MD,PhD
toril.dammen@medisin.uio.no
+4790163433
Time Frame
Start Date: 2022-11-30
Estimated Completion Date: 2024-12-20
Participants
Target number of participants: 64
Treatments
Experimental: Attention Training Techniqe
The treatment manual will consist of up to six weekly group sessions with 45-90 minutes duration.
No_intervention: Wait-list control
The wait-list control condition will not receive any psychological intervention during the six weeks waiting period. Subsequently, this group will also receive the intervention if the study entry criteria is still fulfilled
Related Therapeutic Areas
Sponsors
Collaborators: The Hospital of Vestfold, University of Oslo, Oslo University Hospital
Leads: Vestre Viken Hospital Trust

This content was sourced from clinicaltrials.gov